SEBI

SEBI gives approval to Niva Bupa for Rs 3,000 crore IPO

Niva Bupa Health Insurance on Monday said it has received final approval from the capital markets regulator, the Securities and Exchange Board of India (SEBI), to raise Rs 3,000 crore through an initial public offering (IPO). 15 days ago
New chip-based blood test can diagnose heart attacks in minutes

AI and Synthetic Biology in Disease Diagnosis and Treatment

AI and Synthetic Biology are transforming healthcare, enhancing efficiency and accuracy in disease diagnosis and treatment. Synthetic Biology allows the production of bioactive compounds in non-natural hosts, revolutionizing the pharmaceutical industry. 20 days ago